MILLENNIUM MANAGEMENT LLC
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1273087
NEW YORK, NY
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,668,056
-$1,172,363 QoQ
Shares Held
1,649,490
-8.2% QoQ
Ownership
0.639%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Derivatives in MRVI
reported options exposure · as of Mar 31, 2024CallValue
$520,200
CallShares
60,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,466,124,984 across 340 Biotechnology names. MRVI ranks #176 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in MRVI
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-23 | $37,054,385 | 6,900,258 | Shares | Sole | 2026-06-29 | |
| 2026-06-16 | $36,690,835 | 7,323,520 | Shares | Sole | 2026-06-23 | |
| 2026-05-06 | $28,481,724 | 7,228,864 | Shares | Sole | 2026-05-12 | |
| 2026-03-31 | $4,668,056 | 1,649,490 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,840,419 | 1,797,052 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,261,947 | 439,703 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $597,889 | 248,087 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,042,553 | 1,376,721 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,394,572 | 1,907,261 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,943,342 | 4,325,312 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,735,118 | 5,968,592 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $45,560,442 | 5,254,953 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $520,200 | 60,000 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $37,903,860 | 5,786,849 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $1,442,965 | 220,300 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $42,621,990 | 4,262,199 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $1,200,000 | 120,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $1,180,850 | 95,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $2,752,163 | 221,413 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $145,605 | 10,393 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $429,300 | 30,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $37,142,291 | 2,595,548 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $45,858,875 | 1,796,274 | Shares | Sole | 2022-11-14 | |
| 2022-09-30 | $2,394,714 | 93,800 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $3,103,877 | 109,253 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $2,272,800 | 80,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $23,443,228 | 664,679 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,855,836 | 521,619 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,589,050 | 378,750 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $15,801,064 | 378,650 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,030,162 | 365,605 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $19,794,828 | 705,698 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||